Response to the Letter to the Editor Entitled “Revisiting Vincristine for FSGS: Proof-of-Mechanism Arrives, but Whom Should we Treat?”Kidney International ReportsIF5.72025-12-240OAAI
Organ-specific features of human kidney lymphatics are disrupted in chronic transplant rejectionJOURNAL OF CLINICAL INVESTIGATIONIF13.62025-09-162OA
Vincristine treatment protects against podocyte damage in focal segmental glomerulosclerosis长春新碱治疗可保护局灶节段性肾小球硬化中的足细胞损伤Kidney International ReportsIF5.72025-08-140OAAI
Single-cell transcriptomics identifies aberrant glomerular angiogenic signalling in the early stages of WT1 kidney diseaseJOURNAL OF PATHOLOGYIF5.22024-08-230OA
Pseudouridylation defect due to DKC1 and NOP10 mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitisPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12020-06-1730OAAI
Mutations in LAMB2 Are Associated With Albuminuria and Optic Nerve Hypoplasia With HypopituitarismJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMIF5.12019-11-267OAAI